Hook: On July 18, 2024, Liang Wenfeng’s High-Flyer deployed 153 distinct private fund products into the IPO subscription of ChangXin Memory Technologies (CXMT). Not one. Not two. One hundred and fifty-three. Each product is a legal fiction—a pipeline designed to bypass the single-product subscription cap. The prospectus lists 8.78 yuan per share. The market whispers a 2-5 trillion yuan valuation. The gap between these two numbers is not optimism. It is a signal of structural market manipulation, dressed in the garb of national champion semiconductor strategy.
Context: CXMT is China’s sole DRAM manufacturer, currently producing 17nm DDR5 chips at a reported 60-70% yield—roughly 20 percentage points below Samsung’s legacy 1z node. The company is widely seen as a linchpin of Beijing’s semiconductor self-sufficiency drive. But this IPO is not about funding R&D. It is about cashing out before the equipment ban hits. High-Flyer, a quantitative hedge fund with $10 billion in AUM and a reputation for algorithmic alpha, is not a passive retail investor. Its founder, Liang Wenfeng, also controls DeepSeek, a large-language model startup that consumes vast amounts of HBM memory—a product CXMT does not produce. The logical thread: High-Flyer needs HBM for AI training, CXMT lacks HBM, yet High-Flyer invests billions in CXMT. This is not a supply-chain hedge. It is a speculative bet on a narrative that the technology cannot support.
Core: The 153-fund structure is the first red flag. Under Chinese securities law, a single product can only subscribe for up to 10% of the offering. By spawning 153 discrete legal entities, High-Flyer can effectively control a significant portion of the retail float without triggering disclosure thresholds. This is not a vote of confidence. It is a concentration risk engineered by lawyers. The funds are likely empty shells, funded by a single central treasury, making the offering appear oversubscribed to retail followers. Second, the valuation assumes a 20-30% market share in DRAM by 2030. But CXMT’s current market share is 3%. To hit 20% within six years, it would need to triple capacity from 10,000 wafers per month to 30,000, while simultaneously closing a 3-4 year technology gap in HBM and 1β nodes. No single company in DRAM history has achieved such a leap without licensing from the incumbents. Third, the 17nm node uses DUV lithography from ASML, which is already under Dutch export controls. CXMT pre-ordered equipment before the 2022 restrictions, but those machines will need maintenance. ASML’s service contracts require periodic updates. If the Netherlands follows US guidance—and it will—CXMT’s fabs will face downtime. The prospectus mentions none of this. The risk of a full BIS entity listing is high probability, not tail risk. When the equipment stops, the capacity vanishes, and the valuation collapses.
But let me be precise about numbers. The IPO price implies a P/E ratio of 50-60x on estimated 2024 net profit of 30-40 billion yuan, or $4-5.5 billion. Samsung trades at 15x. SK Hynix at 12x. The premium is not driven by fundamentals but by a regulatory moat: no other domestic DRAM company exists. Yet a moat filled with water when the upstream pipe is controlled by a hostile state is not a moat; it is a swimming pool. Every wafer out of CXMT’s fab requires US-origin EDA tools, Japanese photoresist, and Dutch steppers. The supply chain is as fragile as a zero-day exploit in a smart contract. And the metaphor is intentional: in crypto, we audit code. Here, the code is the manufacturing process, and the audit reveals 30% higher costs per bit than Samsung. That cost disadvantage is not eroded by time. It is locked in by the inability to access next-generation 1β tools.
Contrarian: The bull case is not without merit. China’s government is funneling capital through the third phase of the Big Fund, totaling 344 billion yuan, directly into memory. CXMT’s capacity is pre-sold to domestic phone makers (Xiaomi, Oppo) and server manufacturers (Huawei, Inspur). The demand floor exists. And High-Flyer’s participation could signal a strategic pivot: Liang Wenfeng may use the IPO as a vehicle to co-develop near-memory computing or custom HBM for DeepSeek’s AI workloads. If that materializes, the 2 trillion yuan valuation becomes a floor, not a ceiling. Furthermore, the DRAM market is cyclical—2024 is an upcycle after the 2023 crash. Prices for DDR5 are rising 20-30% year-on-year. CXMT will ride that wave for the next 18 months, generating cash flow that can finance the second fab. The 153 funds may simply be an efficient way to capture a large allocation in a hot IPO. The market does not care about technology gaps when the ticket size is fixed.
Takeaway: The bull case trades on timing and policy. The bear case trades on physics and trade law. History suggests that when the time horizon extends beyond the next semiconductor cycle, physics wins. CXMT is not a blockchain startup with a governance token; it is a physical factory that requires cleanrooms, maintenance contracts, and unfettered access to global supply chains. The 153-fund structure is a volatility amplifier, not a yield enhancer. When the equipment ban hits—and it will—the liquidity will drain faster than a rug pull on an unverified pool. Ledger balances do not lie; they only wait. And in this ledger, the only certainty is that the hype will evaporate before the next generation of chips reaches the tape-out. Receipts remain.
